Evaluation of serum iron and ferritin in different treatment regimens for chronic hepatitis C virus

Journal Title: IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) - Year 2016, Vol 11, Issue 4

Abstract

This work aims to develop a biochemical study on the effect of both interferon containing treatment regimens and interferon free regimens on serum iron and serum ferritin in patients with chronic hepatitis C and to evaluate the role of iron in the severity and course of disease. Blood samples from one hundred fifty patients aged from 25 to 57 years old were withdrawn; of them 30 blood samples were positive for HCV antibodies and negative for HCV RNA (control group I) and 120 blood samples were positive for HCV antibodies and positive for HCV RNA (diseased group II) which is subdivided into four groups according to the received treatment; interferon and ribavirin (group IIa), interferon, sofosbuvir and ribavirin (group IIb), sofosbuvir and ribavirin (group IIc) and herbal therapy (group IId). After treatment there was an extremely significant decrease in iron levels (94 ± 16.96 µg/dL) in group IIa, , while there was an extremely significant increase in iron levels after treatment in group IIb and group IIc (160.4 ± 37.53 µg/dL and 183.7 ± 37.36 µg/dL), respectively. Group IId showed a non significant decrease in iron levels after treatment (150.5 ± 21.35 µg/dL). For ferritin levels, group IIa, group IIb and group IIc showed significant increase in serum ferritin levels after treatment (157.6 ± 13.44, 99.5 ±14.99, and 96.63 ± 15.22 ng/mL), respectively. On the other hand, group IId showed a non significant increase in ferritin levels after treatment (90.93 ± 6.883 ng/mL). It can be concluded that serum ferritin increases in HCV patients treated with combined pegylated interferon--alfa (PEG-IFN)-ribavirin than the other treatment regimens. In addition, Serum iron decreases in HCV patients treated with combined PEG-IFNribavirin, while serum iron increases in sofosbuvir dual and trible therapy.

Authors and Affiliations

Fagr B. Bazeed, Elsherbeny H. Elsayed, Amani A. Abd El-Aziz2

Keywords

Related Articles

Comparative Testing of Antibacterial Activity of Aqueous Extract of Bergenia Ligulata Rhizomes and Ethanolic Extract of Butea Monosperma Flowers for Herbal Gel Formulation

The aim of this research was to formulate a gel comprising of the both extracts of Bergenia ligulata rhizomes and Butea monosperma flowers that would aid in wound healing by exhibiting antibacterial activity at the site...

Nanoscale Biomaterials for 3D printing

Bio printing is an emerging tool for differentiating stem cells in 3D patterns. This technique provides the platform for regeneration of organs and tissues in a systematic manner.The use of suitable biomaterial with its...

Blood Supply of female reproductive system of Lepuscapansisarabicus (Arabain hare)

The anatomy of the arterial and venous vessels of the mammalian oviduct is well describedin women and in laboratory and farm animals. The arteries are derived from the ovarian anduterine stems; the relative contribution...

Taxonomy of Subfamily Caesalpinioideae (Fabaceae Lindl.) In Cerrado Fragment In The East From Maranhão, Northeast From Brazil

The objective of this research was to present a taxonomic treatment of the subfamily Caesalpinioideae (Fabaceae) in a Cerrado fragment in East from Maranhão, in Northeast Brazil. The Cerrado area sampled belongs to the m...

Impact of oil effluent on the enzyme activity in blood serum of freshwater food fish Cirrhinus mrigala

The purpose of this study was to estimate the acute toxicity of oil effluent on Cirrhinus mrigala and to evaluate the lethal levels. The 120 hrs median lethal concentration of oil effluent were found to be 20ppt for Cirr...

Download PDF file
  • EP ID EP385014
  • DOI 10.9790/3008-1104011319
  • Views 116
  • Downloads 0

How To Cite

Fagr B. Bazeed, Elsherbeny H. Elsayed, Amani A. Abd El-Aziz2 (2016). Evaluation of serum iron and ferritin in different treatment regimens for chronic hepatitis C virus. IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS), 11(4), 13-19. https://europub.co.uk/articles/-A-385014